Spectral Imaging for Disease Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ophthalmic imaging techniques face challenges in diagnosing neurodegenerative diseases and systemic pathologies due to the lack of specificity in revealing disease-specific phenotypes, as features like vascular alterations can be present in multiple diseases, making it difficult to effectively diagnose conditions beyond the eye, such as Alzheimer's disease.
Innovation Solution
The method involves generating spectral image data and analyzing scattering components to identify features associated with disease-specific phenotypes in the eye, using a system with a light source, imaging sensor, and control system to emit light and analyze data for biological properties, allowing for the identification of features indicative of diseases like Alzheimer's.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional ophthalmic imaging techniques are used to detect retinal features, then the imaging process is simple and widely accessible, but the diagnostic specificity for neurodegenerative diseases is insufficient due to non-specific features like vascular alterations
Solution Approach 1:
The imaging system segments the retinal tissue into multiple spectral bands, analyzing different wavelength ranges to identify specific scattering patterns. This segmentation of spectral information allows differentiation of disease-specific phenotypes from non-specific vascular alterations, thereby improving diagnostic specificity without requiring a completely new imaging platform
Solution Approach 2:
The system changes the parameter of light wavelength by capturing spectral image data across multiple bands. By analyzing how different tissue components scatter light at different wavelengths, the system can identify disease-specific phenotypes that are not visible in conventional single-wavelength imaging, thus enhancing diagnostic precision
2Measurement precision
If hyperspectral imaging or metabolic imaging techniques are employed to detect pathological features, then more detailed biological information is obtained, but the techniques fail to yield features indicative of disease-specific phenotypes
Solution Approach 1:
The system extracts specific scattering components from the complex spectral image data by identifying and isolating patterns that correspond to disease-specific phenotypes. This extraction process filters out non-specific information (like general vascular alterations) while retaining and emphasizing features indicative of neurodegenerative diseases, thereby improving information quality
Solution Approach 2:
The system employs feedback mechanisms where the analyzed spectral data is compared against known disease phenotype patterns. This feedback loop allows the system to iteratively refine its identification of disease-specific features, ensuring that the information extracted is both accurate and clinically relevant
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the effective identification of disease-specific features in the eye, improving diagnostic efficacy for neurodegenerative diseases and systemic pathologies by providing reproducible spectral image data and physiological insights, aiding in the formulation of medical opinions and assessment of therapeutic efficacy.
Implementation Method 1
analyzing the spectral image data to identify a plurality of scattering components in the spectral image data, each of the plurality of scattering components being associated with one or more biological properties of the sample
Data Source
AI summary
A method includes generating spectral image data reproducible as one or more spectral images of a plurality of regions of interest in a sample. The method also includes analyzing the spectral image data to identify a plurality of scattering components in the spectral image data, each of the plurality of scattering components being associated with one or more biological properties of the sample. The method also includes identifying a feature of interest in the sample based at least in part on one or more the identified plurality of scattering components.